Global Pharma Grade Nitric Oxide Market Size, Share and Trends Analysis Report, By End-User (Hospital and Healthcare Centre) Forecast (2022-2028)

The global pharma grade nitric oxide market Demand Is Expected to Grow Between CAGR of 7% To 9% During 2022-2028. Pharma grade nitric oxide is used together with a breathing machine and other agents to treat newborn babies with respiratory failure that is caused by pulmonary hypertension. Nitric oxide is a gas that is inhaled through the nose or mouth. It is also used to widen and stimulate the release of certain hormones, such as insulin and human growth hormones. The global pharma grade nitric oxide market is growing due to the rising prevalence of respiratory failures in newborn children. According to the Forum of International Respiratory Society 2017, around 65 million people suffer from chronic obstructive pulmonary disease and almost 3 million people die every year globally. Additionally, the ongoing COVID-19 pandemic is also boosting the demand for the global pharma grade nitric oxide market. Hospitals are the major end-users in the market as nitric oxide is used together with a ventilator machine which can only be applied in hospitals.
Some of the major players in the market include Mallinckrodt, Praxair Technology, Inc., Air Liquide, and Novartis AG among others. These market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and launches, to stay competitive in the market. For instance, in March 2021, Claritas, LLC announced its strategic collaboration with Salzman Group for the development of Claritas’ nitric oxide-releasing compound, R-107, for the treatment of COVID-19, influenza, and other viral infections. Similarly, in February 2022, Glenmark Pharmaceuticals Ltd. and SaNOtize Research and Development Corp. launched their Nitric Oxide nasal spray after the approval from the Drugs Controller General of India to treat adult patients with COVID-19.

Market Coverage
The market number available for – 2022-2028
Base year- 2021
Forecast period- 2022-2028

Segment Covered-
By Application

Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World

Competitive Landscape-
Mallinckrodt, Praxair Technology, Inc., Air Liquide and Novartis AG, among others.

Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Global Pharma Grade Nitric Oxide Market Report by Segment
By Application
Hospital
Healthcare Centre